The largest database of trusted experimental protocols

26 protocols using cd14 pe

1

Plasma Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
To 50 μL of plasma, 5 μL of CD14 PE and 5 μL of CD16 PECy7 (Biolegend, San Diego, CA) were added. Simultaneously, compensation beads (eBioscience, San Diego, CA) were incubated with the antibodies. Isotype controls for the antibodies of interest (IgG1 k, PE and IgG1 k PECy7) were included. Samples were analyzed by flow cytometry (BD Biosciences, LSRII, San Jose, CA). The instrument was cleaned before analyzing each set of samples. Filtered water, phosphate-buffered saline, and antibodies alone were also tested to confirm elimination of background. Size beads (sub-micron particle size reference kit, ThermoFisher Scientific, .1, .2, .5 and 1 μm) functioned as size markers, and a log scale for forward scatter and side scatter parameters was used. Flow cytometry gates were set at <1 μm and .2 μm. Flow analysis was performed with FlowJo software (FlowJo, LLC, Ashland, OR).
+ Open protocol
+ Expand
2

Flow Cytometry Analysis of Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
The flow cytometry was carried out using the BD FACSCanto II Cell Analyzer (BD Bioscience). The analysis of THP-1 macrophages, human classical monocytes, and Kupffer cells was performed as described previously with some modifications (Tian et al., 2016 (link)). Briefly, cells were collected and incubated with primary antibodies IgG2a-PE, IgG1-APC, CD14-PE, APC anti-human CD11b antibody (Biolegend, #301310), APC anti-human CD16 antibody (Biolegend, #360705), F4/80-PE (eBioscience, #12-4801-82), or IgG2a-PE (eBioscience, #12-4321-80) at 4°C for 30 minutes. Cells were rinsed with PBS three times before the flow cytometry analysis. Data were analyzed by FlowJo 10 software (BD Bioscience)
+ Open protocol
+ Expand
3

Quantifying Monocytes and Viability in SVF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following SVF isolation from the whole WAT, the pellet enriched for the SVF is resuspended and used either for monocyte/macrophage detection and quantification or for assessing cell viability in response to treatment with metformin. Monocyte/macrophage detection and quantification was assessed by staining with commercially validated antibodies CD14-PE (BioLegend; Cat#301806, clone:M5E2), CD45-FITC (BioLegend; Cat#304005, clone: HI30), CD206-BV-421 (BioLegend; Cat#321125, clone: 15-2), CD3-APC (BioLegend; Cat#317318, clone: OKT3). All antibodies were diluted 1:100 in 100 μl FACS buffer (1% BSA, 5 mM EDTA, 0.05% Sodium Azide in PBS) and incubated at 4 °C, for 30 min. SVF was then centrifuged at 300 g for 5 min and resuspended in Dead/Live stain diluted 1:200 (Thermo Fisher Scientfic; Cat#L34975) and incubated for further 10 min on ice. Cells were then centrifuged at 300 g for 5 min and fixed in 1% PFA before flow cytometry. For measuring cell viability, SVF was stained with APC- Annexin V (1:30 dilution) and propidium iodide (PI; 1:50 dilution) according to the manufacturer's instructions (BioLegend; Cat#79998). All samples were acquired on a LSRFortessa flow cytometer (BD Biosciences, USA) and data were analysed with FlowJo software, version 10 (Tree Star Inc. Ashland, OR, USA).
+ Open protocol
+ Expand
4

Flow Cytometry Analysis of Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
The flow cytometry was carried out using the BD FACSCanto II Cell Analyzer (BD Bioscience). The analysis of THP-1 macrophages, human classical monocytes, and Kupffer cells was performed as described previously with some modifications (Tian et al., 2016 (link)). Briefly, cells were collected and incubated with primary antibodies IgG2a-PE, IgG1-APC, CD14-PE, APC anti-human CD11b antibody (Biolegend, #301310), APC anti-human CD16 antibody (Biolegend, #360705), F4/80-PE (eBioscience, #12-4801-82), or IgG2a-PE (eBioscience, #12-4321-80) at 4°C for 30 minutes. Cells were rinsed with PBS three times before the flow cytometry analysis. Data were analyzed by FlowJo 10 software (BD Bioscience)
+ Open protocol
+ Expand
5

Flow Cytometry Analysis of Lung Tissue Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To validate results from the GSVA immune enrichment in the LTRC, we used flow cytometry, a non-mRNA related method. Fresh lung tissue samples of IPF patients undergoing bilateral lung transplant at the University of Pittsburgh (USA) were washed with PBS and enzymatically digested as previously described [34 (link)]. Lung homogenates included multiple areas of the same lung lobe, ensuring the representability of the sample to address patient’s heterogeneity. Lung tissue homogenates (106 cells) were then stained 5 min with the viability staining (Fixable viability-Alexa600, BD, USA) and 30 min at 4ºC in the dark with the following conjugated monoclonal antibodies CD3-PECy5.5, CD45-Alexa700, CD16-BV412, CD56-FITC, CD8-V500, CD4-APC-Cy7, CD19-BV650 (BD, USA) and CD14-PE (BioLegend, USA). A minimum of 5 × 105 cells per sample were acquired in a FACS LSRII (BD Biosciences, USA), and data was analyzed using FlowJo v10 (FlowJo LLC, USA). Immune cell populations were determined using the gating strategy depicted in Additional file 1: Fig. S1.
+ Open protocol
+ Expand
6

Immunophenotyping of GMSCs and Splenocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
GMSCs were collected and suspended in cell staining buffer (0.5% BSA in PBS with 2 mM EDTA) followed by incubation with CD14 (PE), CD19 (PerCP-Cy5.5), CD29 (APC), CD34 (PE), CD44 (FITC), CD45 (PE), CD73 (PE), CD90 (FITC), and CD105 (PE) antibodies (Biolegend) in the dark at room temperature for 30 min. For intracellular staining, splenocytes from mice were first stained with CD3 (APC/Cy7), CD4 (FITC), and CD25 (APC) antibodies (Biolegend) and then fixed, permeabilized, and stained intracellularly for IL-4 (PE/Cy7) and IL-17 (PE). After staining, cells were washed twice with PBS and submitted to flow cytometric analysis (BD). Data were analyzed using the FlowJo 7.6 software.
+ Open protocol
+ Expand
7

Isolation and Culture of Mouse Mammary Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary mouse MEC cultures were isolated from both inguinal and/or thoracic mammary glands and prepared as described [17 (link)]. MEC suspensions and flow cytometry were performed as previously described [40 (link)]. Antibodies against mouse antigens were purchased from Biolegend and included CD24-PB (#101820), CD31 (#102410), CD45 (#103112), and Ter119 (#116212) conjugated to APC, CD29–FITC (#102206), and CD14-PE (#123309). Cells were sorted on a FACSAria or FACSDiva (BD PharMingen) and manually counted prior to plating on irradiated fibroblast feeders as described [40 (link)]. After 7 days, colonies were fixed and stained with Giemsa and manually counted. To induce R26creERT2-mediated deletion, 0.1 μM 4OHT was added to culture medium for 20 hours on day 1 of culture.
+ Open protocol
+ Expand
8

Immune Cell Isolation from Surgical Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immediately post-excision, surgical specimens were placed in isotonic saline on ice and rapidly processed. Briefly, tissues were weighed, placed onto a piece of 250 μm Nitex mesh and dissociated with a mortar and pestle in HBSS + 10% FBS. Cells were washed 2X with HBSS + 10% FBS and after the final wash were layered over a Ficoll-Paque gradient and centrifuged according to the manufacturer's instructions (GE Healthcare, Uppsala, Sweden). Leukocytes were collected from the interface, washed, and counted. Cells were then incubated with Human FcR Receptor Binding Inhibitor (eBioscience, San Diego, CA) to minimize non-specific antibody binding. Cells were then stained with directly-conjugated antibodies for multi-color flow cytometry analysis, which included anti-human CD66b-FITC (BioLegend, San Diego, CA), CD14-PE, CD16-APC, CD33-PE-Cy5, HLA-DR-PE-Cy7, CD45-eFluor450, CD3-APC-Cy7, CD11b-BV510 and CD11c-BV605. All fluorochrome-conjugated antibodies were purchased from either BD or eBioscience unless otherwise noted. To exclude dead cells from analysis, a Live/Dead Fixable Stain Kit (Life Technologies, Eugene, OR) was used according to the manufacturer's instructions. Controls included cells stained with isotype control antibodies to assess the degree of non-specific staining. Analysis was performed using BD FACSDiva software with cells gated on the live CD45+ leukocyte population.
+ Open protocol
+ Expand
9

Evaluating Immune Responses to Extracellular Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy EVs with or without LL37 were used to stimulate healthy PBMCs for determining IP10, IL1β and IFNα positive cells. Healthy PBMCs were stimulated with EV or EV/LL37 complex for 6 h and 16 h in the presence of Brefeldin-A (5 µg ml–1, Biolegend, Cat#420601) for IL1β and IP10 analysis, respectively. Of note, Brefeldin-A was added at t = 0 and t = 6th hour of incubation for IL1β and for IP10, respectively. The cells were then fixed with Fix & Perm Medium A (Invitrogen, Cat# GAS001S100). Cells were first stained with CD14-PE (Biolegend, Cat#325606) and then to detect the level of intracellular IL1β or IP10 were stained wither with IL1β-FITC (e-Biosciences, Cat# 12-7018-81) or IP10-Biotin (BD, Cat# 555048) then SA-FITC (Biolegend, Cat# 405202) in the presence of saponin (0.1%).
IFNα secreting cells were analysed with Miltenyi Biotech’s (San Diego, CA, USA) IFNα Secretion Assay and Detection Kit (PE-labelled, Miltenyi, Cat# 130-094-161) from PBMCs in accordance with kit instructions. Additionally, in order to identify IFNα secreting pDCs, cells were stained with BDCA-2-FITC (Biolegend, Cat# 354208) and then analysed by BD Accuri C6 flow cytometer.
+ Open protocol
+ Expand
10

Profiling Monocyte Subsets by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were incubated with mixtures of fluorochrome-conjugated antibodies, and identified by flow cytometry. Data acquisition and analysis were performed using a BD CANTO II Flow Cytometer and BD FACS DIVA software (BD Biosciences, Flanklin Lakes, New Jersey). Dead cells were distinguished by 7-amino-actinomycin D (7-AAD, BD Biosciences) staining. Cells were not permeabilized for intra-staining. To identify monocyte lineage cells, the surface markers CD14-PE (Biolegend, San Diego, California, clone HCD14) and CD16-APC/Cy7 (Biolegend, clone 3G8) were used. Pro-inflammatory and anti-inflammatory phenotypes were characterized using S100A9-FITC (BioRad, Hercules, California, clone MAC387) and CD163-APC (Biolegend, clone RM3/1) antibodies (Supplementary Table). S100A9 and CD163 expression levels were determined using a positive dataset for each antibody, identified using a matched concentration of mouse IgG1 kappa isotype control for fluorochrome color (Biolegend, clone MOPC21).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!